Mirena Lawsuit News: Bernstein Liebhard LLP Notes New Study Pointing to Age as Factor in IUD Expulsion Risk

Share Article

The Firm is representing numerous women who allegedly experienced uterine perforations and other serious Mirena complications due to spontaneous migration of the IUD.

Free Case Review
Our Firm is representing many young women in Mirena lawsuits, and we are monitoring all developments related to this device.

As Mirena lawsuits (http://www.mirenalawsuit2014.com/ ) move forward in courts throughout the U.S., Bernstein Liebhard LLP notes the publication of a new study which suggests that age may be a factor in the expulsion of the IUD. The research, which was published this month by the American College of Obstetrics & Gynecology, looked at over 5,000 women who used an IUD, including the levonorgestrel IUD (currently sold under the brand name Mirena) . The study authors found the overall IUD expulsion rate to be just over 10%. Among younger women, ages 14 to 19, 18.8 per 100 experienced this complication. The rate for expulsion among older women was 9.4 per 100.*

“These findings are interesting, especially as a growing number of health experts are now advocating IUDs like Mirena for teen girls. Our Firm is representing many young women in Mirena lawsuits, and we are monitoring all developments related to this device with great interest,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free case evaluations to women who were allegedly harmed after their Mirena IUD spontaneously migrated from its proper position in the uterus.

Mirena IUD Lawsuits
The Mirena IUD is a long-acting contraceptive that is inserted into the uterus by a healthcare provider, where it emits a low dose of levonorgestrel, a synthetic progestin, for up to five years. Mirena was initially approved by the U.S. Food & Drug Administration (FDA) in 2000 for contraception. In 2009, the agency also approved Mirena for the prevention of heavy menstrual bleeding in women who wish to use an IUD as their primary method of birth control.** In 2009, the FDA issued a Warning Letter to Bayer Healthcare Pharmaceuticals after finding that one of the company’s Mirena promotions made misleading claims about the safety and efficacy of the IUD.

Just last month, the American Academy of Pediatrics recommended IUDs and other long-acting birth control methods as first-line choices for teen girls. Among other things, the group pointed out that these methods are more reliable than condoms or birth control pills used by most teenagers.***

According to court documents, thousands of women are currently pursuing Mirena IUD lawsuits for injuries allegedly caused by spontaneous migration of the device. Nearly 1,100 such claims have been filed in a multicounty litigation established in New Jersey’s Bergen County Superior Court, where Bernstein Liebhard LLP is currently filing cases. (In Re: Mirena Litigation; Case No. 297) More than 1,000 additional lawsuits have also been filed in a federal multidistrict litigation now underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)

Court filings indicate that all of these lawsuits similarly allege that spontaneous migration of the IUD resulted in uterine perforations, expulsion, scarring, adhesions, infections, infertility, and other serious Mirena complications. Plaintiffs accuse Bayer of downplaying the risks associated with the IUD, and of failing to warn that the device might migrate even after being properly inserted into the uterus by a healthcare provider. Among other things, the complaints point out that the Mirena label only warns that migration might occur if the uterus is perforated when the IUD is being implanted.

Alleged victims of serious Mirena complications associated with spontaneous IUD migration may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a Mirena lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free legal consultation, please call 800-511-5092.

*ncbi.nlm.nih.gov/pubmed/25198262, American College of Obstetrics & Gynecology, October 2014
**fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm184747.htm, October 2009
health.usnews.com/health-news/articles/2014/09/29/pediatricians-endorse-iuds-implants-for-teen-birth-control, HealthDay News, September 29, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website